AMES, Iowa, May 30, 2012 (GLOBE NEWSWIRE) -- NewLink Genetics (Nasdaq:NLNK) announced today that Dr. Charles Link, Chairman and Chief Executive Officer, will present at the Jefferies 2012 Global Healthcare Conference in New York on Wednesday, June 6, 2012, at 4:30 p.m. (EDT). Dr. Link’s presentation will include an update from the American Society of Clinical Oncology (ASCO) 2012 Annual Meeting taking place June 1-5, 2012 including data from the Company’s HyperAcute products and IDO Pathway Inhibitor Therapies.
